ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (1y) (2014 - 2025)
ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -10.39% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27.27% |
| Mar 31, 2025 | 49.58% |
| Sep 30, 2024 | -25.18% |
| Jun 30, 2024 | -39.25% |
| Mar 31, 2024 | -37.58% |
| Sep 30, 2023 | 29.60% |
| Jun 30, 2023 | -16.12% |
| Mar 31, 2023 | -20.70% |
| Sep 30, 2022 | -45.01% |
| Jun 30, 2022 | -0.62% |
| Mar 31, 2022 | 129.76% |
| Dec 31, 2021 | 137.25% |
| Sep 30, 2021 | 77.43% |
| Jun 30, 2021 | 74.96% |
| Mar 31, 2021 | 75,532.96% |
| Dec 31, 2020 | -27.03% |
| Sep 30, 2020 | 24.70% |
| Jun 30, 2020 | 3.59% |
| Mar 31, 2020 | -99.90% |
| Dec 31, 2019 | 102,727.55% |